IMPORTANT SAFETY INFORMATION
DIASTAT
® AcuDial™ (diazepam rectal gel) is a gel formulation
of diazepam intended for rectal administration in the management of selected,
refractory patients with epilepsy, on stable regimens of AEDs, who require
intermittent use of diazepam to control bouts of increased seizure activity
for patients 2 years and older.
In clinical trials with DIASTAT
®, the most frequent side effect
was somnolence (23%). Less frequent adverse events reported were dizziness,
headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination,
asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see
full
DIASTAT AcuDial Prescribing Information.